Ciprofloxacin News and Research

RSS

SALVAT submits complete response to FDA approvable letter for CETRAXAL

SALVAT announced today the submission of the response to the FDA Approvable Letter for CETRAXAL (Ciprofloxacin 0.2% Otic Solution in Single Dose Containers).

6 Nov 2008

Contact lenses are home to pathogenic amoebae

Contact lenses increase the risk of infection with pathogenic protozoa that can cause blindness. New research, published in the November issue of the Journal of Medical Microbiology, shows that a high percentage of contact lens cases in Tenerife are contaminated with Acanthamoeba that cannot be killed by normal contact lens solution.

20 Oct 2008

Drugs and fruit juices - a combination to avoid

It has been common knowledge for a number of years that grapefruit juice can influence the absorption of certain drugs, potentially turning normal doses into toxic overdoses.

20 Aug 2008

New reasons to avoid grapefruit juice when taking certain drugs

Scientists and consumers have known for years that grapefruit juice can increase the absorption of certain drugs - with the potential for turning normal doses into toxic overdoses.

19 Aug 2008

Fluoroquinolones can enhance gene-silencing tool

A way to turn off one gene at a time has earned acceptance in biology laboratories over the last decade. Doctors envision the technique, called RNA interference, as a tool to treat a variety of diseases if it can be adapted to humans.

20 Jul 2008

Poultry workers at greater risk of carrying antibiotic-resistant E. coli

Poultry workers in the United States are 32 times more likely to carry E. coli bacteria resistant to the commonly used antibiotic, gentamicin, than others outside the poultry industry, according to a recent study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health.

18 Dec 2007

Dual action anthrax vaccine-antitoxin combination developed

The immune response generated in rats by the new agent protects against lethal toxin exposure after only one injection, and is faster and stronger than any currently available vaccine.

8 Oct 2007

Novel respiratory antibiotic Cethromycin, shown to be effective against Anthrax

Advanced Life Sciences Holdings has announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection.

4 May 2007

CDC warns about threat of drug resistant gonorrhoea

According to the U.S. Centre for Disease Control and Prevention (CDC), gonorrhoea affects as many as 700,000 Americans each year and the sexually transmitted disease has now become so drug resistant doctors are running out of options with which to treat it.

16 Apr 2007

FDA approves generic Ciprofloxacin injection

The Food and Drug Administration has approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corporation Pharmaceutical Division's CIPRO I.V., a drug to treat certain bacterial infections.

29 Aug 2006

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

3 May 2006

Less antibiotic use in food animals leads to less drug resistance in people

Australia's policy of restricting antibiotic use in food-producing animals may be linked with lower levels of drug-resistant bacteria found in its citizens, according to an article in the May 15 issue of Clinical Infectious Diseases.

18 Apr 2006

Quinolone antibiotic eardrops best for treating middle ear infections

Topical quinolone antibiotics can clear aural discharge better than systemic antibiotics. This was the finding of a systematic review of literature published in the latest update of The Cochrane Library.

25 Jan 2006

Bayer to produce new Tuberculosis drug at low prices for poor nations

A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.

18 Oct 2005

Scientists identify inhibitors of the anthrax toxin

A collaborative team of scientists led by The Burnham Institute's Maurizio Pellecchia, Ph.D., has identified inhibitors of the anthrax toxin, termed lethal factor ("LF") that could be developed into an emergency treatment for exposure to inhalation anthrax.

21 Jun 2005

Research explains why Shigella and E. coli are rapidly becoming resistant to fluoroquinolones

Scientists at the Albert Einstein College of Medicine have discovered a novel strategy by which the bacterium that causes tuberculosis may soon be able to resist the effects of antibiotics known as fluoroquinolones.

3 Jun 2005

Three-day antibiotic treatment for treating bladder infections in women

A three-day regimen of the antibiotic amoxicillin-clavulanate is not as effective as ciprofloxacin at treating an uncomplicated bladder infection in women, according to a study conducted by Thomas M. Hooton, M.D., of the University of Washington and Harborview Medical Center, Seattle, and colleagues.

21 Feb 2005

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to an article in the October 11 issue of The Archives of Internal Medicine.

11 Oct 2004

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

Pigs and other farm animals are harbouring major reservoirs of antibiotic-resistant bacteria

The scientists were concerned about the effects that decades of use of antibiotics to treat infections, prevent diseases, or promote growth, have had on the spread of antibiotic resistance genes in common farm bacteria.

8 Sep 2004